Aerovate Therapeutics
Price & Volume
Stats
See more52W Range | $1.25-$32.41 |
Market Cap | $77.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.99 |
News
See moreYahoo Finance • last year
Aerovate Therapeutics Announces Simultaneous Completion of Enrollment in Phase 2b Portion and Enrollment of First Patient into Phase 3 in the IMPAHCT Trial Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension
Yahoo Finance • last year
Aerovate Therapeutics Announces Third Quarter Financial Results and Business Highlights
Yahoo Finance • last year
Aerovate Therapeutics Announces Second Quarter Financial Results and Business Highlights
Yahoo Finance • last year
Aerovate Therapeutics Appoints Habib Dable To Its Board of Directors
About
CFO | Mr. George A. Eldridge |
Address | 930 Winter Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 51 |
